Immunotherapies for GBM: Tumor Vaccines by Linda Liau, M.D., Ph.D., M.B.A.

  Рет қаралды 7,500

Seattle Science Foundation

Seattle Science Foundation

Күн бұрын

Пікірлер: 3
@kristinwohlschlagel6622
@kristinwohlschlagel6622 7 жыл бұрын
This was wonderful to see. Thank you so much! I am a Hospice nurse and I had been wondering what the latest information was for GBM patients. I am especially glad to learn about the difference in mid-point and tail-end outcomes ~~ very encouraging!
@bobbaj1775
@bobbaj1775 7 жыл бұрын
Hello Murali I have been following this treatment for a couple of years now and I can mention that everything that I read finds the QOL for patents have been best described as NORMAL.. This people have no side effects from the treatments and are moving on with their daily lifes. Excuse - They do develop a rash at the injection site. As silly as that sounds thats it a small rash (redness).
@muralis9478
@muralis9478 7 жыл бұрын
What's been the quality of life for some of these survivors Dr. Liau? The example you gave of the patient who's perhaps into his 14th year of survival with a son who was little when he began treatment and now in high school. Perhaps you can give us a general feel on his QOL?
Into the Brain (Virtual Reality) - Neil A. Martin, MD
43:11
Seattle Science Foundation
Рет қаралды 1,2 М.
Individual Treatments for Glioblastoma - Charles S. Cobbs, MD
30:10
Seattle Science Foundation
Рет қаралды 4,6 М.
Help Me Celebrate! 😍🙏
00:35
Alan Chikin Chow
Рет қаралды 64 МЛН
The Joker wanted to stand at the front, but unexpectedly was beaten up by Officer Rabbit
00:12
Когда отец одевает ребёнка @JaySharon
00:16
История одного вокалиста
Рет қаралды 5 МЛН
WCM Neurosurgery Grand Rounds: Dr  Linda Liau
59:52
Weill Cornell Medicine Neurological Surgery
Рет қаралды 8 М.
Methylene Blue and Near Infrared Light for Neuroprotection
38:06
Long Story Short
Рет қаралды 110 М.
Introduction to GBM Research
41:14
The Ahmed Lab: Northwestern Neurosurgery
Рет қаралды 5 М.
Levodopa: Myths, Facts, and YOUR Questions Answered
1:23:40
APDA Northwest
Рет қаралды 19 М.
Targeting Cancer Pathways: Understanding Immune Checkpoints
1:00:44
Cell Signaling Technology, Inc.
Рет қаралды 34 М.
ADD/ADHD | What Is Attention Deficit Hyperactivity Disorder?
28:15
Understood
Рет қаралды 9 МЛН
Personalized Approach to Glioblastoma Therapy by Michael Prados, MD
26:33
Seattle Science Foundation
Рет қаралды 3,7 М.